Renal Effects of Iopentol and Iohexol after Intravenous Injection

References

• Albrechtsson U., Hultberg B., Lárusdóttir H., Norgren L. Nephrotoxicity of ionic and non-ionic contrast media in aorto-femoral angiography. Acta Radiol. Diagnosis 1985; 26: 615
   PubMedGoogle Scholar
• Berg K. J., Jakobsen J. Å. Nephrotoxicity related to contrast media. Patient safety and adverse events in contrast medium examinations, I. Enge, J. Edgren, Amsterdam 1989; 111, Excerpta Medica, Int. Congr. Ser. 816.
   Google Scholar
• Iopentol. Chemistry, toxicology and pharmacology of a non-ionic contrast medium. Acta Radiol. 1987, Suppl. No. 370, Bousen E., Kormano M.
   Google Scholar
• Cavaliere G., Arrigo G., D'Amico G., et al. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency. Nephron 1987; 46: 128
   PubMed Web of Science ®Google Scholar
• Cedgård S., Herlitz H., Geterud K., Attman P.-O., Aurell M. Acute renal insufficiency after administration of low-osmolar contrast media. Letter. Lancet 1986; II: 1281
   Google Scholar
• D'Elia J. A., Gleason R. E., Alday M., et al. Nephrotoxicity from angiographic contrast material. A prospective study. Am. J. Med. 1982; 72: 719
   PubMed Web of Science ®Google Scholar
• Gale M. E., Robbins A. H., Hamburger R. J., Widrich W. C. Renal toxicity of contrast agents. Iopamidol, iothalamate, and diatrizoate. AJR 1984; 142: 333
   PubMed Web of Science ®Google Scholar
• Hartmann H. G. Enzymuria after administration of water-soluble X-ray contrast media. Contrast media in urography, angiography and computerized tomography, V. Taenzer, E. Zeitler. Georg Thieme Verlag, Stuttgart 1983; 30
   Google Scholar
• Hartmann H. G., Jutzler G. A., Bambauer R., Keller H. E., Maruhn D. Enzymbestimmungen im Harn zur Beurteilung der Nierenverträglichkeit des wasserlöslichen Röntgen-Kontrastmittels Iopamidol. Radiologe 1984; 24: 442
   PubMed Web of Science ®Google Scholar
• Jakobsen J. Å., Berg K. J., Waaler A., Andrew E. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers. Acta Radiol. 1990; 31: 87
   PubMed Web of Science ®Google Scholar
• Jakobsen J. Å., Hagve T.-A., Holager T., et al. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial. Eur. J. Radiol. 1989; 9: 203
   Google Scholar
• Jevnikar A. M., Finnie K. J. C., Dennis B., Plummer D. T., Avila A., Linton A. L. Nephrotoxicity of high- and low-osmolality contrast media. Nephron 1988; 48: 300
   PubMed Web of Science ®Google Scholar
• Khoury G. A., Hopper J. C., Varghese Z., et al. Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br. J. Radiol. 1983; 56: 631
   PubMedGoogle Scholar
• Kolbenstvedt A. K., Aspestrand F., Knudsen H., Jakobsen J. Å., Rydning A., Berg K. J. Iopentol compared with iohexol for abdominal CT. Iopentol. Clinical trials with a new non-ionic contrast medium, F. Lærum, B. Kendall. Elsevier, Amsterdam 1990; 33
   Google Scholar
• Langer M., Junge W., Keysser R., Hasford J., Jänicke U.-A. Renal and hepatic tolerance of nonionic and ionic contrast media in intravenous digital subtraction angiography. Recent development in non-ionic contrast media, V. Taenzer, S. Wende. Georg Thieme Verlag, Stuttgart 1989; 95
   Google Scholar
• Levorstad K., Kolbenstvedt A., Kolmannskog F., et al. Tolerability of iohexol after injection into healthy volunteers. Acta Radiol. Diagnosis 1983; 24: 241
   PubMedGoogle Scholar
• Parfrey P. S., Griffiths S. M., Barrett B. J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N. Engl. J. Med. 1989; 320: 143
   PubMed Web of Science ®Google Scholar
• Price N. G., Dance N., Richards B., Cattell W. R. The excretion of N-acetyl-ß-D-glucosaminidase and ß-galactosidase following surgery to the kidney. Clin. Chim. Acta 1970; 27: 65
   PubMed Web of Science ®Google Scholar
• Scherberich J. E., Tuengerthal S., Kollath J. Monitoring of contrast media nephrotoxicity by specific kidney tissue proteinuria of membrane antigens. Contrast media in urography, angiography, and computerized tomography, V. Taenzer, E. Zeitler. Georg Thieme Verlag, Stuttgart 1983; 37
   Google Scholar
• Schwab S. J., Hlatky M. A., Pieper K. S., et al. Contrast nephrotoxicity. A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N. Engl. J. Med. 1989; 320: 149
   PubMed Web of Science ®Google Scholar
• Stacul F., Carraro M., Magnaldi S., Faccini L., Guarnieri G., dalla Palma L. Contrast agent nephrotoxicity. Comparison of ionic and nonionic contrast agents. AJR 1987; 149: 1287
   Google Scholar
• Uthmann U., Geisen H. P., Glück E. Urinary ß-2-microglobulin determinations in assessment of tubular dysfunction after X-ray contrast media application. Contrast media in urography, angiography and computerized tomography, V. Taenzer, E. Zeitler. Georg Thieme Verlag, Stuttgart 1983; 43
   Google Scholar
• Wibell L. Studies of ß₂-microglobulin in human serum, urine and amniotic fluid. Thesis, Uppsala University. 1974
   Google Scholar
• Zachrisson B. E., Jagenburg R. Comparison of iohexol with metrizoate in urography. A single blind parallel investigation. Acta Radiol. 1983, Suppl. No. 366: 30
   Google Scholar